UNII-275N4RXX0Q,
2242-65-1,
epi-Medroxy Progesterone 17-Acetate,
NSC-119085,
275N4RXX0Q,
6-Epimedroxyprogesterone acetate,
Megestrol acetate impurity F [EP],
AC1L6TJ8,
6beta-Methyl-17alpha-hydroxyprogesterone acetate,
6beta-Methyl-3,20-dioxopregn-4-en-17-yl acetate,
Medroxyprogesterone acetate specified impurity D [EP],
Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6beta)-,
NSC119085,
ZINC118913756,
NSC 119085,
17-Hydroxy-6|A-methylprogesterone Acetate,
6|A-Methyl-17|A-hydroxyprogesterone acetate,
17-Acetyloxy-6beta-methylpregna-4-ene-3,20-dione,
17-Hydroxy-6|A-methylpregn-4-ene-3,20-dione Acetate,
(6|A)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione,
[(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate,
Progesterone acetate,
Medroxyprogesterone acetate,
KST-1A2853,
AR-1A7050,
CID273700,
(6|A)-6-methyl-3,20-dioxopregn-4-en-17-yl acetate,
2255-39-2,
302-23-8,